Evidence-based position paper on Physical and Rehabilitation Medicine (PRM) professional practice for persons with sarcopenia. The European PRM position (UEMS PRM Section)
Abstract
Sarcopenia is a progressive and generalized disorder of skeletal muscles associated with accelerated loss of muscle mass and function. Individuals suffering from sarcopenia need rehabilitation services due to its significant impact on their functional abilities. The aim of this evidence-based position paper (EBPP) is to improve Physical and Rehabilitation Medicine (PRM) physicians' professional practice in sarcopenia. A systematic review of the literature and a consensus procedure by means of a Delphi method process have been performed involving the delegates of all European countries represented in the UEMS PRM Section. The systematic literature review is reported together with the 25 main recommendations resulting from the Delphi procedure. It is recommended that PRM physicians play a significant role in taking preventive measures for sarcopenia in older individuals and in developing an Individual Rehabilitation Project for maintaining and improving functioning and reducing disability in individuals with sarcopenia. This EBPP represents the official position of the European Union through the UEMS PRM Section and designates the professional role of PRM physicians in persons with sarcopenia.
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.